PainCeptor Pharma Corp.

Founded in 2004, PainCeptor is focused on the development of novel analgesics for the treatment of moderate to severe chronic pain. Recently raised $23M to advance its product development programs to clinical trials. Drug development efforts target acid sensing ion channels & neurotreophin receptors expressed in peripheral pain sensing neurons.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Bio
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Pain

Markets Covered

a. HeadQuarter: Canada

b. Continent(s) active: North America , Europe

c. Countries active: North America

Corporate data:

Number of Employees: 25

Turnover:

Amount:	Year:	Currency:
n.a.	2002	US Dollar

Year founded: 2004

Partners / Alliances: Painceptor’s drug development efforts are further strengthened through its strategic alliance with NeuroSearch A/S (publicly traded Danish company).